Maine CDC is operating Hepatitis Testing and Linkage to Care under an active Willing & Qualified contracting framework through September 30, 2027. The current State procurement record identifies this as an ongoing Maine CDC / Infectious Disease and Epidemiology service supported by federal SAMHSA funding.
Current contracting framework
Official procurement record CT NOI 1220251130 covers Hepatitis Testing and Linkage to Care. The current contract period is October 1, 2025 through September 30, 2027. Maine CDC states that the purpose is to expand hepatitis C testing and link patients who test positive to medical care, particularly in high-burden areas of Maine.
The State identifies Penobscot, Washington, Kennebec, Aroostook, and Cumberland Counties as high-burden areas for this work. Target populations include people who inject drugs, people who are incarcerated or reentering communities, people without health insurance or Medicaid coverage, and people living at or below 200% of the Federal Poverty Guidelines.
Qualification controls
The procurement justification emphasizes providers with access to high-risk populations and the ability to conduct infectious-disease testing and linkage-to-care services. It specifically discusses Federally Qualified Health Centers and selected providers that offer substance-use treatment services, viral hepatitis and HIV testing, and linkage to care. Maine CDC states that participating providers must meet Department qualifications and be willing to perform the required services.
The Department does not intend to competitively procure these services and instead awards them on a Willing & Qualified basis. The public W&Q table directs interested vendors to the Department contract administrator identified in the accompanying procurement document.
Current funding
The current attachment lists three funded agreements totaling $220,000: City of Portland, $74,000; MaineGeneral Medical Center, $72,000; and Penobscot Community Health Center, $74,000. Those organizations are current contract holders for this service period and should not be treated as unsent applicants for the same award.
Atlas assessment
Atlas Opportunity Score: 82/100. The pathway is active, clinically relevant, and tied to a defined statewide public-health need with a current contract term through September 30, 2027.
N9+ Fit Score: 38/100. The service scope is primarily hepatitis testing, infectious-disease screening, and linkage to care. Remote physical-exam technology is not identified as an allowable or required component in the current procurement record, so N9+ fit is secondary and should not be represented as part of the State-funded scope without separate validation.
Dr. Miltie direct W&Q prime fit: 10/100. The prime-provider role requires specialized infectious-disease testing and linkage-to-care capability for high-risk populations. Dr. Miltie should not be represented as independently meeting those provider requirements without verified evidence.
Recommended next action
Treat the three listed organizations as incumbents. For any prospective new W&Q provider, first verify current incremental funding availability with Maine CDC and confirm the provider can meet the infectious-disease testing, high-risk population access, and linkage-to-care requirements. Any outreach must then pass normal CRM contact verification, Email Opt-Out, actual sent-history, and organization+exact-opportunity deduplication gates.
Official sources: Maine Office of State Procurement Services — Willing & Qualified Vendor Agreements; Procurement Justification Form — Hepatitis Testing and Linkage to Care, CT NOI 1220251130.